Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia

FLT3 mutations are the most common genomic alteration detected in acute myeloid leukemia (AML) with a worse clinical prognosis. The highly frequent FLT3 mutations, together with the side effects associated with clinical prognosis, make FLT3 promising treatment targets and have provoked the advanceme...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Moo-Kon, Park, Byeong-Bae, Uhm, Ji-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604443/
https://www.ncbi.nlm.nih.gov/pubmed/36293564
http://dx.doi.org/10.3390/ijms232012708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604443/
https://www.ncbi.nlm.nih.gov/pubmed/36293564
http://dx.doi.org/10.3390/ijms232012708

Ejemplares similares